tiprankstipranks
Surface Oncology downgraded to Neutral from Outperform at Wedbush
PremiumThe FlySurface Oncology downgraded to Neutral from Outperform at Wedbush
1y ago
Surface Oncology downgraded to Neutral from Outperform at Baird
Premium
The Fly
Surface Oncology downgraded to Neutral from Outperform at Baird
1y ago
Surface Oncology downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Surface Oncology downgraded to Neutral from Buy at H.C. Wainwright
1y ago
Surface Oncology presents new preclinical data on SRF114
PremiumThe FlySurface Oncology presents new preclinical data on SRF114
2y ago
Surface Oncology announces anticipated near-term corporate milestones
Premium
The Fly
Surface Oncology announces anticipated near-term corporate milestones
2y ago
Surface Oncology sees cash runway into 3Q24
Premium
The Fly
Surface Oncology sees cash runway into 3Q24
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100